Japan Tissue Engineering Co., Ltd. Logo

Japan Tissue Engineering Co., Ltd.

Pioneers regenerative medicine with tissue products, CDMO services, and research models.

7774 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
蒲郡市三谷北通6丁目209番地の1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Japan Tissue Engineering Co., Ltd. (J-TEC) is a pioneering biotechnology company focused on the commercialization of regenerative medicine. The company operates through three primary segments: the Regenerative Medicine Business, which develops, manufactures, and sells tissue-engineered medical products such as autologous cultured cartilage; the Custom Development & Manufacturing (CDMO) Business, offering contract services for cell and gene therapy developers; and the LabCyte Business, providing cultured human tissue models for research and safety testing. A member of the Teijin Group, J-TEC was the first company to commercialize regenerative medicine in Japan and aims to establish it as a standard of care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-19 10:05
Post-Annual General Meeting Information
臨時報告書
Japanese 27.0 KB
2025-06-19 07:20
Governance Information
内部統制報告書-第27期(2024/04/01-2025/03/31)
Japanese 21.7 KB
2025-06-19 07:18
Registration Form
確認書
Japanese 8.3 KB
2025-06-19 07:16
Annual Report
有価証券報告書-第27期(2024/04/01-2025/03/31)
Japanese 920.6 KB
2024-11-13 06:09
Regulatory News Service
確認書
Japanese 8.2 KB
2024-11-13 06:07
Interim Report
半期報告書-第27期(2024/04/01-2025/03/31)
Japanese 188.4 KB
2024-06-19 07:50
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2024-06-19 07:48
Governance Information
内部統制報告書-第26期(2023/04/01-2024/03/31)
Japanese 21.5 KB
2024-06-19 07:46
Registration Form
確認書
Japanese 8.3 KB
2024-06-19 07:45
Annual Report
有価証券報告書-第26期(2023/04/01-2024/03/31)
Japanese 907.6 KB
2024-02-13 06:39
Regulatory News Service
確認書
Japanese 8.3 KB
2024-02-13 06:38
Quarterly Report
四半期報告書-第26期第3四半期(2023/10/01-2023/12/31)
Japanese 169.5 KB
2023-11-14 07:22
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-11-14 07:18
Quarterly Report
四半期報告書-第26期第2四半期(2023/07/01-2023/09/30)
Japanese 195.9 KB
2023-08-10 08:23
Report Publication Announcement
確認書
Japanese 8.3 KB

Automate Your Workflow. Get a real-time feed of all Japan Tissue Engineering Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Japan Tissue Engineering Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Orion Oyj Logo
Develops and manufactures human/vet pharma, APIs, and generics for global markets.
Finland ORNAV
Orum Therapeutics, Inc. Logo
Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.
South Korea 475830
Otsuka Holdings Co., Ltd. Logo
Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.
Japan 4578
Ovoca Bio Plc Logo
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
Ireland OVXA
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo
A former biopharma firm that developed non-addictive, cannabinoid-based pain therapies.
United Kingdom OCTHF
PAION AG Logo
Developed drugs for hospital-based sedation, anesthesia, and critical care.
Germany PA8
Pangen Biotech Inc. Logo
Develops biosimilars and provides CHO-based CDMO services for the global biopharma industry.
South Korea 222110
Pentixapharm Holding AG Logo
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
Germany PTP
PeopleBio, Inc. Logo
Develops blood tests for early diagnosis of neurodegenerative diseases like Alzheimer's.
South Korea 304840

Talk to a Data Expert

Have a question? We'll get back to you promptly.